Biofrontera Management
Management criteria checks 4/4
Biofrontera's CEO is Hermann Luebbert, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is $733.23K, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 0.27% of the company’s shares, worth $19.57K. The average tenure of the management team and the board of directors is 2.1 years and 3 years respectively.
Key information
Hermann Luebbert
Chief executive officer
US$733.2k
Total compensation
| CEO salary percentage | 64.2% |
| CEO tenure | 1.5yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.1yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
Biofrontera Inc.'s (NASDAQ:BFRI) Shares Leap 25% Yet They're Still Not Telling The Full Story
Sep 28
Further Upside For Biofrontera Inc. (NASDAQ:BFRI) Shares Could Introduce Price Risks After 40% Bounce
Aug 09Take Care Before Jumping Onto Biofrontera Inc. (NASDAQ:BFRI) Even Though It's 29% Cheaper
May 24Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%
Dec 30The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%
Nov 13Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?
Oct 18Biofrontera announces preliminary Q3 product revenue, stock falls ~7% after hours
Oct 05Biofrontera gets notice of allowance for U.S. patent covering a nanoemulsion formulation
Sep 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$13m |
| Jun 30 2024 | n/a | n/a | -US$14m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$733k | US$471k | -US$20m |
| Sep 30 2023 | n/a | n/a | -US$26m |
| Jun 30 2023 | n/a | n/a | -US$23m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$1m | US$475k | -US$640k |
| Sep 30 2022 | n/a | n/a | -US$12m |
| Jun 30 2022 | n/a | n/a | -US$26m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | US$1m | US$18k | -US$38m |
Compensation vs Market: Hermann's total compensation ($USD733.23K) is about average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Hermann's compensation has been consistent with company performance over the past year.
CEO
Hermann Luebbert (68 yo)
1.5yrs
Tenure
US$733,225
Compensation
Dr. Prof. Hermann Luebbert, Ph.D. is a Co-Founder of Biofrontera AG and served as its Chief Executive Officer since 1997 until December 13, 2021 and served as its Chairman of Management Board since 2000 un...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Chairman | 1.5yrs | US$733.23k | 0.27% $ 19.6k | |
| Chief Financial Officer | 2.1yrs | US$441.68k | no data | |
| Senior Director of Finance & Principal Accounting Officer | no data | no data | no data | |
| Vice President of Scientific & Medical Affairs | 1.8yrs | no data | no data | |
| Vice President of Administration | 2.8yrs | no data | no data | |
| General Counsel & Head of Compliance | 5.8yrs | no data | no data | |
| Vice President of Sales & Marketing | no data | no data | no data |
2.1yrs
Average Tenure
Experienced Management: BFRI's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Chairman | 9.7yrs | US$733.23k | 0.27% $ 19.6k | |
| Independent Director | 3yrs | US$68.64k | no data | |
| Director | 1.3yrs | US$19.36k | no data | |
| Independent Director | 2.7yrs | US$58.01k | no data | |
| Independent Director | 3yrs | US$64.47k | no data |
3.0yrs
Average Tenure
66yo
Average Age
Experienced Board: BFRI's board of directors are considered experienced (3 years average tenure).